Pacira Pharmaceuticals, Inc.

10450 Science Center Drive
San Diego, CA 92121
(858) 625 2424

5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560

TAKING CARE OF PATIENTS, TODAY AND TOMORROW

Company Overview

Corporate Profile
Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam® drug delivery technology, for use in hospitals and ambulatory surgery centers.
Stock Quote
PCRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$77.62
Change (%) Stock is Up 0.04 (0.05%)
Volume494,478
Data as of 05/22/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/20/15Pacira Pharmaceuticals, Inc. to Present at Investor Conferences in June
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 20, 2015-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave Stack, president, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present an overview of the company at the following investor conferences in June: Jefferies 2015 Global Healthcare Conference at 11:30 a.m. ET in New York on Monday, June 1, 2015. Goldman ... 
Printer Friendly Version
05/19/15Pacira Announces New Data Supporting Clinical and Pharmacoeconomic Utility of EXPAREL in Patients Undergoing Various Surgical Procedures
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 19, 2015-- Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) today announced data from three studies evaluating the clinical and pharmacoeconomic utility of EXPAREL® (bupivacaine liposome injectable suspension) for postsurgical pain control in patients undergoing colorectal surgery, breast reconstruction and total knee replacement surgery. The data were presented this month at the annual meetings of the World Congress of ... 
Printer Friendly Version
05/07/15Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 7, 2015-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave Stack, president, chief executive officer and chairman of Pacira Pharmaceuticals, is scheduled to present at the Bank of America Merrill Lynch 2015 Health Care Conference at 8:40 a.m. PT on Thursday, May 14, 2015, in Las Vegas. Mr. Stack is expected to present an overview of the company. A live audio webcast of the ... 
Printer Friendly Version
04/30/15Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results
EXPAREL® Net Sales up 63% from Prior Year Period Conference Call Today at 9 a.m. ET PARSIPPANY, N.J.--(BUSINESS WIRE)--Apr. 30, 2015-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today provided updates on EXPAREL® (bupivacaine liposome injectable suspension) for postsurgical pain in the United States and announced consolidated financial results for the first quarter ended March 31, 2015. “With just a two percent... 
Printer Friendly Version

Corporate Presentation

DateTitle
05/13/15
Corporate Presentation
01/22/15
Analyst Day Presentation
Upcoming EventsMore >>
DateTitle
06/01/15 10:30 a.m. ET
Pacira Pharmaceuticals, Inc. at Jefferies 2015 Global Healthcare Conference
06/09/15 10:40 a.m. PT
Pacira Pharmaceuticals, Inc. at Goldman Sachs 36th Annual Global Healthcare Conference
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Pacira Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Contact Investor Relations:
Jessica Cho
(973) 254-3574
Jessica.Cho@pacira.com